{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:15:59Z","timestamp":1790957759872,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":36,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811573590","type":"print"},{"value":"9789811573606","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-981-15-7360-6_20","type":"book-chapter","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T12:03:02Z","timestamp":1617105782000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)\/Nonalcoholic Steatohepatitis (NASH)"],"prefix":"10.1007","author":[{"given":"Tsuguhito","family":"Ota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/ajg.2010.18","volume":"105","author":"LA Adams","year":"2010","unstructured":"Adams LA, Harmsen S, St Sauver JL, Charatcharoenwitthaya P, Enders FB, Therneau T, Angulo P (2010) Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 105:1567\u20131573","journal-title":"Am J Gastroenterol"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","volume":"25","author":"P Angulo","year":"2007","unstructured":"Angulo P (2007) GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 25:883\u2013889","journal-title":"Aliment Pharmacol Ther"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Targher G, Day CP (2013) Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10:330\u2013344","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/90992","volume":"7","author":"AH Berg","year":"2001","unstructured":"Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947\u2013953","journal-title":"Nat Med"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","volume":"48","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48:634\u2013642","journal-title":"Diabetologia"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005\u20132023","journal-title":"Hepatology"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.metabol.2007.11.022","volume":"57","author":"Y Chang","year":"2008","unstructured":"Chang Y, Ryu S, Sung E, Woo HY, Oh E, Cha K, Jung E, Kim WS (2008) Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism 57:569\u2013576","journal-title":"Metabolism"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day CP, James OF (1998) Steatohepatitis: a tale of two \u201chits\u201d? Gastroenterology 114:842\u2013845","journal-title":"Gastroenterology"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2337\/diacare.22.5.756","volume":"22","author":"R de Marco","year":"1999","unstructured":"de Marco R, Locatelli F, Zoppini G, Verlato G, Bonora E, Muggeo M (1999) Cause-specific mortality in type 2 diabetes. The Verona diabetes study. Diabetes Care 22:756\u2013761","journal-title":"Diabetes Care"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99\u2013S112","journal-title":"Hepatology"},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1172\/JCI1018","volume":"102","author":"JP Iredale","year":"1998","unstructured":"Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102:538\u2013549","journal-title":"J Clin Invest"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/j.1464-5491.2005.01582.x","volume":"22","author":"S Jimba","year":"2005","unstructured":"Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, Wasada T (2005) Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 22:1141\u20131145","journal-title":"Diabet Med"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.22950","volume":"50","author":"KR Karlmark","year":"2009","unstructured":"Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F (2009) Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50:261\u2013274","journal-title":"Hepatology"},{"key":"20_CR14","first-page":"434","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434\u2013438","journal-title":"Mayo Clin Proc"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50","author":"G Marchesini","year":"2001","unstructured":"Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844\u20131850","journal-title":"Diabetes"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cmet.2008.04.003","volume":"7","author":"JI Odegaard","year":"2008","unstructured":"Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, Subramanian V, Mukundan L, Ferrante AW, Chawla A (2008) Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab 7:496\u2013507","journal-title":"Cell Metab"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1053\/j.gastro.2006.10.014","volume":"132","author":"T Ota","year":"2007","unstructured":"Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y et al (2007) Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 132:282\u2013293","journal-title":"Gastroenterology"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1172\/JCI32752","volume":"118","author":"T Ota","year":"2008","unstructured":"Ota T, Gayet C, Ginsberg HN (2008) Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J Clin Invest 118:316\u2013332","journal-title":"J Clin Invest"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/eje.1.01821","volume":"152","author":"C Pagano","year":"2005","unstructured":"Pagano C, Soardo G, Esposito W, Fallo F, Basan L, Donnini D, Federspil G, Sechi LA, Vettor R (2005) Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol 152:113\u2013118","journal-title":"Eur J Endocrinol"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/00005176-200001000-00017","volume":"30","author":"M Rashid","year":"2000","unstructured":"Rashid M, Roberts EA (2000) Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 30:48\u201353","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","volume":"53","author":"V Ratziu","year":"2010","unstructured":"Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G (2010) A position statement on NAFLD\/NASH based on the EASL 2009 special conference. J Hepatol 53:372\u2013384","journal-title":"J Hepatol"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2337\/diabetes.49.5.749","volume":"49","author":"L Ryysy","year":"2000","unstructured":"Ryysy L, Hakkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Jarvinen H (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749\u2013758","journal-title":"Diabetes"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/MCG.0b013e31819e9048","volume":"43","author":"S Savvidou","year":"2009","unstructured":"Savvidou S, Hytiroglou P, Orfanou-Koumerkeridou H, Panderis A, Frantzoulis P, Goulis J (2009) Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. J Clin Gastroenterol 43:765\u2013772","journal-title":"J Clin Gastroenterol"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2337\/db06-0263","volume":"55","author":"PE Scherer","year":"2006","unstructured":"Scherer PE (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55:1537\u20131545","journal-title":"Diabetes"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan D, Kim YO (2013) Evolving therapies for liver fibrosis. J Clin Invest 123:1887\u20131901","journal-title":"J Clin Invest"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.22952","volume":"50","author":"E Seki","year":"2009","unstructured":"Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, Schwabe RF, Brenner DA (2009) CCR2 promotes hepatic fibrosis in mice. Hepatology 50:185\u2013197","journal-title":"Hepatology"},{"key":"20_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122:787\u2013795","journal-title":"J Clin Invest"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","volume":"60","author":"F Tacke","year":"2014","unstructured":"Tacke F, Zimmermann HW (2014) Macrophage heterogeneity in liver injury and fibrosis. J Hepatol 60:1090\u20131096","journal-title":"J Hepatol"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1053\/j.gastro.2004.07.019","volume":"127","author":"T Takehara","year":"2004","unstructured":"Takehara T, Tatsumi T, Suzuki T, Rucker EB 3rd, Hennighausen L, Jinushi M, Miyagi T, Kanazawa Y, Hayashi N (2004) Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology 127:1189\u20131197","journal-title":"Gastroenterology"},{"key":"20_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00125-007-0897-4","volume":"51","author":"G Targher","year":"2008","unstructured":"Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, Muggeo M (2008) Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 51:444\u2013450","journal-title":"Diabetologia"},{"key":"20_CR31","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52:1836\u20131846","journal-title":"Hepatology"},{"key":"20_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.26607","volume":"59","author":"J Wan","year":"2014","unstructured":"Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, Pecker F, Tran A, Gual P, Mallat A et al (2014) M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 59:130\u2013142","journal-title":"Hepatology"},{"key":"20_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124\u2013131","journal-title":"Gastroenterology"},{"key":"20_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"RJ Wong","year":"2015","unstructured":"Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, Ahmed A (2015) Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148:547\u2013555","journal-title":"Gastroenterology"},{"key":"20_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0030-1255354","volume":"30","author":"TA Wynn","year":"2010","unstructured":"Wynn TA, Barron L (2010) Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30:245\u2013257","journal-title":"Semin Liver Dis"},{"key":"20_CR36","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1038\/ncomms8158","volume":"6","author":"J Xue","year":"2015","unstructured":"Xue J, Sharma V, Hsieh MH, Chawla A, Murali R, Pandol SJ, Habtezion A (2015) Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun 6:7158","journal-title":"Nat Commun"}],"container-title":["Advances in Experimental Medicine and Biology","Carotenoids: Biosynthetic and Biofunctional Approaches"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-15-7360-6_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T12:05:54Z","timestamp":1617105954000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-15-7360-6_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9789811573590","9789811573606"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/978-981-15-7360-6_20","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"31 March 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}